A burgeoning industry is quietly taking shape in Canada, offering private delivery of entheogens – a phenomenon fueled by growing acceptance in their potential therapeutic benefits and a largely untested legal landscape. Consumers seeking access from conditions like depression, anxiety, and PTSD are increasingly turning to these niche services, … Read More